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A variety of pathologies of autoimmune dis­
eases and allergic diseases are caused by the 
immune responses to self, environmental non­
microbial antigens, and infectious agents. Regu­
latory  T cells (Treg cells), which are characterized 
by  expression  of  the  Forkhead  transcription 
factor, Foxp3, play an indispensable role in 
immunological tolerance, protecting the host 
from excessive immune responses (Hori et al., 
2003; Sakaguchi, 2004; Sakaguchi et al., 2008; 
Belkaid and Tarbell, 2009). Foxp3 plays an essen­
tial role in the suppressive function of Treg cells 
(Wan and Flavell, 2007), and Foxp3 deficiency 
causes a multiorgan autoimmune disease as can 
be observed in the scurfy mouse and in patients 
with IPEX (immunodysregulation polyendo­
crinopathy enteropathy X­linked syndrome; 
Bennett and Ochs, 2001; Bennett et al., 2001; 
Brunkow et al., 2001). Foxp3 induction in nat­
ural Treg cells (nTreg cells) occurs in vivo during 
thymic differentiation, under the influence of 
relatively high avidity interactions of the TCR 
with self­antigens.
Although the suppression of autoimmunity 
by Treg cells is now well established, recently, 
nTreg  cells  have  been  shown  to  convert  to   
effector/helper T cells (Komatsu et al., 2009). 
Although most Treg cells retain high Foxp3 ex­
pression after adoptive transfer to a nonpatho­
genic setting, 10–15% of Treg cells were found 
to lose Foxp3 expression after adoptive transfer 
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Regulatory T cells (Treg cells) maintain immune homeostasis by limiting inflammatory  
responses. SOCS1 (suppressor of cytokine signaling 1), a negative regulator of cytokine 
signaling, is necessary for the suppressor functions of Treg cells in vivo, yet detailed mecha-
nisms remain to be clarified. We found that Socs1/ Treg cells produced high levels of  
IFN- and rapidly lost Foxp3 when transferred into Rag2/ mice or cultured in vitro, even 
though the CNS2 (conserved noncoding DNA sequence 2) in the Foxp3 enhancer region  
was fully demethylated. Socs1/ Treg cells showed hyperactivation of STAT1 and STAT3.  
Because Foxp3 expression was stable and STAT1 activation was at normal levels in  
Ifn/Socs1/ Treg cells, the restriction of IFN-–STAT1 signaling by SOCS1 is suggested 
to be necessary for stable Foxp3 expression. However, Ifn/Socs1/ Treg cells had hyper-
activated STAT3 and higher IL-17A (IL-17) production compared with Ifn/Socs1+/+  
Treg cells and could not suppress colitis induced by naive T cells in Rag2/ mice. In vitro 
experiments suggested that cytokines produced by Socs1/ Treg cells and Ifn/Socs1/ 
Treg cells modulated antigen-presenting cells for preferential Th1 and Th17 induction, 
respectively. We propose that SOCS1 plays important roles in Treg cell integrity and function 
by maintaining Foxp3 expression and by suppressing IFN- and IL-17 production driven by 
STAT1 and STAT3, respectively.
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Foxp3 levels were preserved in Ifn/Socs1/ Treg cells, 
yet Ifn/Socs1/ Treg cells could still not suppress colitis 
induced by the transfer of naive T cells. To our surprise, 
Ifn/Socs1/ Treg cells produced extremely high levels of 
IL­17, thereby instructing Th17 cell differentiation of naive 
T cells in Rag2/ mice. Il-17/ naive T cells still caused 
colitis but were suppressed by the cotransfer of Ifn/Socs1/ 
Treg cells, which suggests that Ifn/Socs1/ Treg cells instruct 
naive T cells to become colitogenic by producing high levels   
of IL­17. In vitro experiments suggest that cytokines from 
Socs1/ Treg cells play roles in the instruction of Th1 and 
Th17 through APCs. We propose that SOCS1 is a guardian of 
Treg cells because SOCS1 inhibits the conversion of Treg cells 
into Th1­ and Th17­like IFN­– and IL­17–producing cells.
RESULTS
Autoimmune phenotypes caused by LckCre-Socs1f/f mice 
and impaired suppression activity of SOCS1-deficient  
nTreg cells in vivo
As reported previously, T cell–specific Socs1­deleted (Lck-
Cre­Socs1f/f; cKO) mice survived >6 mo (Tanaka et al., 2008), 
yet all of these mice eventually developed dermatitis, spleno­
megaly, and lymphadenopathy with age (Fig. 1, A–C). Inflam­
matory cellular infiltrations in the skin, liver, and kidney were 
observed in these mice (Fig. 1 D). Serum Ig levels were much 
higher in cKO mice than in Socs1f/f (WT) mice, and dsDNA 
antibodies were detected as well (Fig. 1 E). These data suggest 
that cKO mice developed a systemic inflammatory and auto­
immune disease.
The autoimmune phenotype of T cell–specific Socs1­cKO 
mice has been thought to be mostly caused by hyperactiva­
tion of effector T cells and the production of a huge amount 
of IFN­ (Fig. 1 F). Because Ifn/LckCre­Socs1f/f mice did 
not develop dermatitis (not depicted), these phenotypes were 
dependent on IFN­. cKO mice and Socs1f/f littermates were 
crossed with knockin mice with Foxp3­IRES­GFP as re­
ported previously (Wang et al., 2008), and the number of 
nTreg cells was increased in cKO­Foxp3GFP mice in the thy­
mus (Fig. 1 G) and periphery (Zhan et al., 2009). Similar auto­
immune  phenotypes  were  observed  in Treg  cell–specific 
Socs1­deleted mice, Foxp3Cre­Socs1f/f mice (Lu et al., 2010), 
suggesting that SOCS1­deficient nTreg cells have a defective 
suppression activity.
The  defective  suppression  activity  of  SOCS1­deficient 
Treg cells in vivo was confirmed by the failure to suppress 
colitis in Rag2/ mice by the cotransfer of naive T cells 
(Ly5.1) and Treg cells (Ly5.2; Fig. 2 A and Fig. S1). Treg cells 
were purified by FACS sorting as CD3+CD4+CD25+GFP+ 
(>99% Foxp3 positive). 4 wk after transfer, the fraction of 
Foxp3­positive cells from Ly5.2­positive cKO­Foxp3GFP mice 
was significantly decreased compared with those from Ly5.2­
positive WT­Foxp3GFP mice (Fig. 2 B). IFN­ levels in the 
mesenteric LN in Rag2/ mice cotransferred with naive 
T  cells and Socs1/ Treg cells were much higher than in 
Rag2/ mice transferred with naive T cells and WT Treg cells (not   
depicted). These results indicate that the suppressive function 
into lymphopenic hosts. A recent study showed that half of 
Treg cells transferred into lymphopenic hosts did not die, but 
rather  began  producing  IL­2  and  IFN­  (Komatsu  et  al., 
2009). Additionally, multiple recent studies have demonstrated 
that in the inflammatory settings of autoimmunity, there is a 
loss of Foxp3 during inflammatory responses (Zhou et al., 
2009; Murai et al., 2010). The adoptive transfer of Treg cells 
into Cd3/ hosts, which retain B lymphocytes, resulted in 
the loss of Foxp3 expression and the generation of lapsed Treg 
cells that differentiated into follicular helper T cells in Peyer’s 
patches that promoted IgA class switching (Tsuji et al., 2009). 
Such exFoxp3 cells (Zhou et al., 2009) or lapsed Treg cells 
(Murai et al., 2010) develop an effector­memory phenotype, 
produce pathogenic cytokines, and can trigger the develop­
ment of autoimmunity. Two possibilities were proposed regard­
ing the developmental plasticity of Treg cells: (1) the lineage 
reprogramming of the conversion of committed Foxp3+ cells 
to Foxp3 cells or (2) the expansion of uncommitted Treg 
cells, which easily lose Foxp3 (Hori, 2010). In any case, the 
molecular basis for such Treg cell conversion and the signals 
that ensure the stability of Treg cells have not yet been clari­
fied. On the contrary, recent work by Rubtsov et al. (2010) 
reported that highly purified Treg cells were very stable under 
physiological and inflammatory conditions. Such clarification 
is also necessary for the development of applications for trans­
ferring Treg cells to treat autoimmune diseases or to prevent 
rejections of transplantations.
SOCS1 (suppressor of cytokine signaling 1) is apparently 
defined as an important mechanism for the negative regula­
tion of the cytokine–JAK–STAT pathway (Yoshimura et al., 
2007), and uncontrolled IFN­ signaling results from a defi­
ciency of SOCS1. SOCS1 is highly expressed in Treg cells (Lu 
et al., 2009). It has been reported that SOCS1 expression is 
reduced in lupus­affected (NZB × NZW) F1 mice (Sharabi 
et al., 2009), and expression levels of SOCS1 are altered in 
patients with rheumatoid arthritis or systemic lupus erythe­
matosus (Isomäki et al., 2007; Chan et al., 2010). Analyses of 
T cell–specific Socs1 conditional KO (cKO; LckCre­Socs1f/f) 
mice revealed that SOCS1­deficient effector T cells produce 
high levels of IFN­ and low levels of IL­17A (IL­17; Tanaka 
et al., 2008). Although we have shown that the number of 
Foxp3­positive Treg cells in cKO mice is higher than that in 
WT mice (Lu et al., 2009), SOCS1­deficient Treg cells lost 
proper suppression functions in Treg cell–specific Socs1­cKO 
mice (Lu et al., 2010). However, detailed mechanisms for 
the impaired Treg cell function by SOCS1 deficiency remain 
to be clarified.
This study was undertaken to clarify the role of SOCS1 in 
the stability and suppressive function of Treg cells. We observed 
autoimmune phenotypes in T cell–specific Socs1­cKO mice, 
suggesting a defective Treg cell function in these mice. The de­
fective suppression activity of SOCS1­deficient Treg cells was 
confirmed through the failure to suppress colitis in Rag2/ 
mice by the cotransfer of naive T cells and Treg cells. In lym­
phopenic conditions, Socs1/ Treg cells tended to lose Foxp3 
and were easily converted into Th1­like IFN­–producing cells. JEM Vol. 208, No. 10 
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Treg cells. Before transfer, SOCS1­deficient Treg cells expressed 
CD25 and CTLA4 at significantly higher levels than did WT 
Treg cells. After transfer, however, CD25 and CTLA4 were 
more profoundly down­regulated in Socs1/ Treg cells than 
in WT Treg  cells,  in  both  the  Foxp3­maintaining  fraction 
(Foxp3+→+; Fig. 2 E) and the exFoxp3 fraction (Foxp3+→; 
Fig. 2 E, top and bottom). In addition, transferred Socs1/ 
Treg cells produced higher amounts of IFN­ from both the 
Foxp3­maintaining and the Foxp3­losing fractions (Fig. 2 F, 
top and bottom). The Foxp3­maintaining fraction of SOCS1­
deficient Foxp3+ Treg cells also produced IL­2 in addition 
to IFN­ (Fig. 2 G, top and bottom). These results indicate 
that SOCS1­deficient Treg cells tend to lose Foxp3 expres­
sion and produce effector cytokines, thus suggesting that 
SOCS1 is necessary for preventing IFN­–producing exFoxp3 
cell development.
To  exclude  the  possibility  that  the  higher  number  of 
Foxp3 cells in Foxp3+Socs1/ Treg cell transfer was caused 
by an extraordinary expansion of contaminated Foxp3Socs1/ 
cells, activated/memory Socs1/ or Socs1+/+ T cells (Ly5.2+ 
CD44highCD62LFoxp3 cells) were mixed to 3.3% in the co­
transfer of Ly5.1 WT naive T cells and Treg cells (Fig. S3, top) 
or to 5% in the transfer of Ly5.1 WT Treg cells into 
Rag2/ mice (Fig. S3, bottom). Any abnormal ex­
pansion of activated/memory Socs1/ T cells was not 
observed, suggesting that the larger number of Foxp3 
cells in Socs1/ Treg cell transfer was not caused by 
rapid  expansion  of  contaminated  SOCS1­deficient 
Foxp3 T cells.
IL­10 from Treg cells has been shown to play an 
important role in the suppression of naive T cell–
induced colitis in Rag2/ mice (Maloy et al., 2003). 
Thus, we suspected that impaired IL­10 production 
from SOCS1­deficient Treg cells could be a mecha­
nism for SOCS1­deficient Treg cell–mediated colitis. 
However, production of IL­10 was significantly higher 
in Socs1/ Treg cells compared with WT Treg cells 
both before and after transfer, suggesting that IL­10 is 
not involved in the SOCS1­deficient Treg cell–mediated 
colitis (Fig. S4).
of SOCS1­deficient Treg cells was impaired in lymphopenic 
conditions, concomitant with faster loss of Foxp3 expression, 
compared with that of WT Treg cells.
Loss of Foxp3 expression and conversion to Th1-like cells  
of SOCS1-deficient Treg cells in lymphopenic conditions
We then investigated the fate of Foxp3+ cells in lymphopenic 
conditions. Treg cells from WT­Foxp3GFP or cKO­Foxp3GFP 
mice were transferred into Rag2/ mice, and 6 wk later, 
Foxp3 positivity was examined by flow cytometry. WT Treg 
cells lost Foxp3 expression in the single­transfer condition 
more significantly than in the cotransfer with naive T cells, yet 
they did not develop colitis, as shown previously (Komatsu   
et al., 2009). Surprisingly, SOCS1­deficient Treg cells transferred 
into Rag2/ mice developed colitis (Fig. 2 C and Fig. S2). 
SOCS1­deficient Treg cells experienced a more profound loss 
than did WT Treg cells (63.1% Foxp3+ in WT Treg cells vs. 
40.7% in SOCS1­deficient Treg cells; Fig. 2 D).
Not only Foxp3 but also other phenotypical markers of 
Treg cells, CD25 and CTLA4, which have been shown to be 
critical  molecules  in  the  suppression  activity  of Treg  cells 
(Wing et al., 2008), were altered in transferred SOCS1­deficient 
Figure 1.  Characterization of LckCre-Socs1f/f (cKO) 
mice. (A) Representative appearance of a 12-wk-old cKO 
mouse. (B) Incidence of dermatitis in cKO mice (n = 20).  
(C) Representative macroscopic view of the spleen and LN of a 
Socs1f/f (WT) mouse and its age (12 wk old)- and sex-matched 
cKO counterpart. (D) Representative histopathology of the skin, 
liver, and kidneys of a WT mouse and its age (12 wk old)- and 
sex-matched cKO counterpart. Data are representative of five 
independent experiments. Bars, 200 µm. (E and F) Serum titers 
of Ig subclasses and anti-dsDNA antibodies (E) and serum lev-
els of IFN- (F) from WT and cKO mice measured by ELISA. 
Each symbol indicates individual host mouse (*, P < 0.05). Data 
are representative of seven independent experiments. Horizon-
tal bars indicate the mean. (G) Representative Foxp3-GFP ex-
pression on CD3+CD4+ T cells from the thymus of WT and cKO 
mice as determined by flow cytometry.2058 SOCS1 is necessary for Treg cell integrity | Takahashi et al.
CD62Lhigh in Socs1/ Treg cells (Fig. 3 B). As 
reported, Foxp3 expression was decreased in 
the CD62Llow fraction in WT Treg cells, and 
Foxp3  was  maintained  in  the  CD62Lhigh 
fraction (Fig. 3 C, left). In Socs1/ Treg cells, 
Foxp3 was also maintained in the CD62Lhigh 
fraction. However, the loss of Foxp3 expres­
sion in the CD62Llow fraction was signifi­
cantly more drastic in Socs1/ Treg cells than 
in WT Treg cells (Fig. 3 C, right).
Recently, it has been reported that the DNA methylation 
status of the CNS2 region in the Foxp3 enhancer is particu­
larly important for maintenance of Foxp3 expression (Floess 
et al., 2007; Kim and Leonard, 2007; Zheng et al., 2010). To 
examine  whether  SOCS1­deficient  Foxp3+ Treg  cells  con­
tained uncommitted Treg cells or unstable inducible Treg cells 
(iTreg  cells),  we  determined  the  methylation  status  of  the 
CNS2 region in SOCS1­deficient Treg cells. As shown in 
Fig. 3 D, the CNS2 region of Treg cells from the LN of 
SOCS1­cKO mice were fully demethylated, similar to those 
of WT mice (Fig. 3 D). This indicates that >95% SOCS1­
deficient Treg cells were committed and did not contain iTreg 
cells. After 3­d in vitro culture, the Foxp3­maintaining frac­
tion (Foxp3+→+) retained full demethylation in the CNS2 
region in both Socs1+/+ and Socs1/ Treg cells. However, the 
CNS2 region in the exFoxp3 fraction (Foxp3+→) was fully 
Rapid methylation of the CNS2 (conserved noncoding DNA 
sequence 2) region in the Foxp3 enhancer of committed 
SOCS1-deficient Treg cells
Like in Rag2/ mice, Foxp3 levels were decreased more rap­
idly in Socs1/ Treg cells than in WT Treg cells in vitro. CFSE 
dilution revealed that the loss of Foxp3 occurred mostly in 
divided Treg cells, suggesting that the loss of Foxp3 is associ­
ated with cell division or that cells that lost Foxp3 expression 
divide faster than Foxp3+ cells (Fig. 3 A). It has been reported 
that  CD4+CD25+CD62Lhigh Treg  cells  maintained  stable 
Foxp3 expression along with suppressive activity after in vitro 
expansion compared with CD4+CD25+CD62Llow Treg cells 
(Scalapino and Daikh, 2009). Thus, we compared Foxp3 ex­
pression levels in Socs1+/+ and Socs1/ Treg cells between the 
CD62high and CD62Llow fraction after 3­d in vitro culture. 
The fraction of CD62Llow was much higher than that of 
Figure 2.  SOCS1-deficient Treg cells have  
attenuated suppressive function, lose Foxp3  
expression, and produce effector cytokines.   
(A and B) 2 × 105 Treg cells from the LN of Ly5.2 WT-
Foxp3GFP mice (Socs1+/+ Treg cells) or Ly5.2 cKO-Foxp-
3GFP mice (Socs1/ Treg cells) were cotransferred with 
4 × 105 Ly5.1 naive T cells into Rag2/ mice. 4 wk 
later, recipient mice were analyzed. (A) Body weight 
changes. (B) Flow cytometric analysis of Foxp3-GFP 
expression on Ly5.2+CD3+CD4+ T cells from the LN in 
Rag2/ mice (percentage of Foxp3-GFP+ shown in 
bar graph). (C–G) 2 × 105 Socs1+/+ or Socs1/ Foxp3+ 
Treg cells were transferred into Rag2/ mice. 6 wk 
after transfer, recipient mice were analyzed. (C) Body 
weight changes. (D) Flow cytometric analysis of 
Foxp3-GFP expression on CD3+CD4+ T cells from the 
LN in Rag2/ mice (percentage of Foxp3-GFP+ indi-
cated in bar graph). (E) Expression profiles of CD25 
and intracellular CTLA4 on CD3+CD4+GFP+ cells and 
GFP cells from the LN in Rag2/ mice (right) com-
pared with those on CD3+CD4+GFP+ cells before 
transfer (left; mean fluorescent intensity [MFI], bot-
tom). (F) Flow cytometric analysis of Foxp3-GFP and 
IFN- expression on CD3+CD4+cells from the LN in 
Rag2/ mice (percentage of IFN-+ shown in bar 
graph below). (G) Expression of IFN- and IL-2 on 
CD3+CD4+GFP+ cells from the LN in Rag2/ mice 
(percentage of IL-2– and IFN-–producing cells indi-
cated in bar graph). (A–G) Data are representative  
of three independent experiments (*, P < 0.05;  
**, P < 0.01). Values represent the mean ± SD.JEM Vol. 208, No. 10 
Article
2059
TCR stimulation and IL­2, much higher amounts of IFN­ 
as well as of IL­17 were produced from Socs1/ Treg cells 
than from WT Treg cells. IL­12 further up­regulated IFN­ 
production, whereas IL­17 was up­regulated by IL­1 and IL­6 
(Fig. 4 A). Interestingly, the production of IL­17 by IL­1 and 
IL­6 was dependent on TGF­ because anti–TGF­ anti­
body abrogated the effect of IL­1 and IL­6.
Because SOCS1 has been shown to be an essential nega­
tive regulator for the JAK–STAT pathway, the activation status 
of STAT1 and STAT3 were compared using immunoblotting 
and intracellular staining (Fig. 4 B). STAT5 was reported to be 
phosphorylated in SOCS1­deficient Treg cells at higher levels 
than in WT Treg cells, which is associated with the increase in 
the number of Treg cells (Lu et al., 2009). Much stronger tyro­
sine phosphorylation of both STAT1 and STAT3 were ob­
served in freshly isolated SOCS1­deficient Treg cells than in 
WT Treg cells by both methods (Fig. 4 B). These data indicate 
that SOCS1 is necessary for the suppression of spontaneous 
activation of STAT1 and STAT3 in Treg cells.
Foxp3 was stabilized in Ifn/Socs1/ Treg cells
Because SOCS1 is a strong inhibitor for the IFN­–STAT1 
pathway, we hypothesized that hyper­STAT1 activation led to 
or partially methylated, and more methylation occurred in the 
SOCS1­defcient exFoxp3 cells than in the SOCS1­suf f icient 
exFoxp3 cells (Fig. 3 D), which is consistent with a more rapid 
loss of Foxp3 in Socs1/ Treg cells than in WT Treg cells.
In vivo, we also found hypermethylation of the CNS2 re­
gion in Foxp3 cells after transfer of Foxp3+ cells into Rag2/ 
mice  (Fig.  3  E).  More  intensive  hypermethylation  in  the 
CNS2 region in Foxp3 cells was observed in Socs1/ Treg 
cell transfer than in WT Treg cell transfer (Fig. 3 E; >90% 
methylated regions were 90% in Socs1/ vs. 50% in Socs1+/+). 
Thus, the CNS2 region of the Foxp3 gene in exFoxp3 cells 
from SOCS1­deficient  Treg cells was more easily hypermethyl­
ated not only in vitro but also in vivo than that from WT 
Treg cells (Fig. 3 E).
Accelerated conversion of SOCS1-deficient Treg cells  
into Th1- and Th17-like cells in vitro
It has been reported that Treg cells convert into Th1­ or Th17­
like cells in appropriate in vitro culture conditions (Yang 
et al., 2008). To investigate the mechanism of the loss of Foxp3 
and  enhanced  IFN­  production  from  Socs1/ Treg  cells   
in vivo, we performed an in vitro conversion assay. As shown 
in Fig. 4 A, when Foxp3+ cells were cultured in the presence of 
Figure 3.  Foxp3 loss in SOCS1-deficient Treg cells 
is associated with cell division and methylation 
of the CNS2 region. (A) Flow cytometric analysis of 
Foxp3 expression in Socs1+/+ and Socs1/ Treg cells 
cultured for 3 d. Numbers on flow plots indicate the 
percentage of divided cells in each group (left). Each 
fraction was analyzed for Foxp3 staining (right).  
(B) Flow cytometric analysis of CD62L and CD44  
expression on CD3+CD4+ T cells (left) and 
CD3+CD4+GFP+ T cells (right) from the LN of cKO mice 
and WT littermate controls. (C) Flow cytometric analy-
sis of Foxp3-GFP expression on CD62Lhigh and 
CD62Llow CD3+CD4+ T cells after 3-d in vitro culture 
(percentage of Foxp3-GFP+ indicated in bar graph). 
Data are representative of three independent experi-
ments (***, P < 0.0001). Values represent the mean ± 
SD. (D and E) Bisulfite sequencing of genomic DNA 
from WT naive T cells and Treg cells from the LN of 
WT-Foxp3GFP and cKO-Foxp3GFP male mice. (D) Meth-
ylation status of the CNS2 region. After Foxp3+  
Treg cells were cultured in vitro for 3 d, Foxp3+ and 
Foxp3 cells were sorted. 10 CpG methylation sites in 
the CNS2 region of the Foxp3 gene were analyzed 
before culture (left) and after 3-d in vitro culture 
(middle and right). Foxp3-maintained cells (Foxp3+→+; 
middle) and Foxp3-lost cells (Foxp3+→; right) are 
shown. (E) Methylation status of the CNS2 region  
4 wk after transfer of Foxp3+ Treg cells into Rag2/ 
mice. Before transfer (left), Foxp3-maintained cells 
(Foxp3+→+; middle), and Foxp3-lost cells (Foxp3+→; 
right) are shown. Percentages of clones displaying 
each methylation status of CpG methylation sites are 
indicated in sector graphs. 10–15 clones were se-
quenced from each subset.2060 SOCS1 is necessary for Treg cell integrity | Takahashi et al.
methylation of the CNS2 region in Treg cells. The rate of 
methylation in the CNS2 region in Ifn/Socs1/ exFoxp3 
cells was lower than that in Ifn/Socs1+/+ exFoxp3 cells. 
These results were consistent with a stable Foxp3 expression 
in Ifn/Socs1+/+ and Ifn/Socs1/ Treg cells after transfer 
into Rag2/ mice.
Ifn/Socs1/ Treg cells still lacked in vivo suppression 
activity because of stronger Th17 instruction
To test the suppression activity, Treg cells from Ifn/Socs1+/+ 
or Ifn/Socs1/ mice were then transferred into Rag2/ 
mice with naive T cells. 4 wk after transfer, Treg cells from 
Ifn/Socs1+/+ mice suppressed colitis elicited by naive T cells 
(Fig. 6 A and Fig. S7). The suppression activity of Ifn/ Treg 
cells was lower than that of Ifn+/+ Treg cells (Figs. 2 A and 6 A), 
yet recipient mice did not develop severe colitis 4 wk after 
T cell transfer. To our surprise, Ifn/Socs1/ Treg cells could 
not prevent colitis, which was confirmed by body weight loss 
and histological examination (Fig. 6 A and Fig. S5). Expression of 
Foxp3 in Ifn/Socs1+/+ Treg cells as well as in Ifn/Socs1/ 
Treg cells was maintained in recipient Rag2/ mice (Fig. 6 B), 
just as it was in the transfer of Treg cells alone (Fig. 2 B). There­
fore, Foxp3 maintenance is not sufficient for the suppression 
of effector T cell functions in vivo.
To understand these unexpected results, we examined the 
production of inflammatory cytokines from Treg cells or 
naive/effector cells transferred into Rag2/ mice. IL­10 
levels were not significantly different between Ifn/Socs1+/+ 
and Ifn/Socs1/ Treg cells (Fig. S4). Because Th17 has also 
been implicated in colitis (Chaudhry et al., 2009; Durant 
et al., 2010), we then compared IFN­ and IL­17 production 
from naive/effector (Ly5.1+) T cells (Fig. 6 C, top) and Treg 
cells (Ly5.1, Ly5.2+; Fig. 6 C, middle) in the LN of trans­
ferred recipient mice, after which percent positivity values of 
cytokine  production  were  determined  by  flow  cytometry 
(Fig. 6 C, bottom). As shown in Fig. 6 C, when naive T cells 
alone were transferred into Rag2/ mice, a portion of these 
cells converted into effector cells that produced mainly IFN­, 
but with very low levels of IL­17 (Fig. 6 C, a). When naive 
T cells and WT Treg cells were cotransferred, differentiation of 
Th1­like cells from naive T cells was completely suppressed 
(Fig. 6 C, b). However, when naive T cells and Socs1/ Treg 
cells were cotransferred, both IFN­– and IL­17–producing 
cells appeared from transferred naive T cells, which is consis­
tent with the failure of suppression of colitis by Socs1/ Treg 
cells (Fig. 6 C, c). Thus, SOCS1­deficient Treg cells promoted 
Th1 and Th17 cell differentiation from naive T cells, whereas 
WT Treg cells did not. In contrast, when naive T cells and 
Ifn/Socs1+/+ Treg cells were cotransferred, a significant frac­
tion of IL­17–producing cells appeared from transferred naive 
T cells (Fig. 6 C, d). IL­17 was also produced from transferred 
Treg cells. These results could explain why Ifn/ Treg cells did 
not prevent colitis very efficiently (Fig. 6 A). Much more intense 
IL­17 production was observed from both naive T cells and 
Treg cell fractions in recipient mice cotransferred with naive   
abnormalities in SOCS1­deficient Treg cells. To address this 
hypothesis, we used Treg cells from Ifn/Socs1/ mice.
Most of the Ifn/Socs1+/+ and Ifn/Socs1/ Treg cells 
(CD4+CD25bright fraction) were CD62Lhigh and CD44high, sug­
gesting that IFN­ deficiency diminished CD62Llow Treg cell 
subsets (Fig. 5 A). Consistently, when Treg cells from both 
Ifn/Socs1+/+ and Ifn/Socs1/ mice were transferred 
into Rag2/ mice, colitis did not develop even 6 wk after 
transfer (Fig. 5 B). Foxp3 expression in Ifn/Socs1/ Treg 
cells was as stable as in Ifn/Socs1+/+ Treg cells and WT Treg 
cells after transfer into Rag2/ mice (Figs. 2 D and 5 C). 
After transfer, unlike in Socs1/ Treg cells, CD25 and CTLA4 
were maintained at significantly higher levels in Ifn/Socs1/ 
Treg cells (Fig. 5 D, top and bottom). We examined the meth­
ylation status of the CNS2 region in both Ifn/Socs1+/+ 
and Ifn/Socs1/ Treg cells in vitro. The CNS2 region of 
Treg cells from the LN of Ifn/Socs1+/+ and Ifn/Socs1/ 
mice were fully demethylated (Fig. 5 E). After 3­d culture, 
the Foxp3­maintaining fraction (Foxp3+→+) retained full de­
methylation in the CNS2 region in both Ifn/Socs1+/+ and 
Ifn/Socs1/ Treg cells. Methylation levels of the CNS2 
region  in  the  Ifn/  exFoxp3  fraction  (Foxp3+→)  were 
lower than those in the Ifn+/+ exFoxp3 fraction (Figs. 3 D 
and 5 E), suggesting that IFN­ played a positive role in the 
Figure 4.  SOCS1-deficient Treg cells convert into Th1- and Th17-
like cells in vitro. (A) 105 Socs1+/+ and Socs1/ Treg cells/well were acti-
vated with anti-CD3/anti-CD28 beads, 10 ng/ml IL-2, and the indicated 
cytokines, and IFN- and IL-17A were measured by ELISA (***, P < 0.0001). 
(B) Detection of phosphorylations of STAT1 and STAT3 in Treg cells with the 
indicated genotypes by immunoblot (left) and flow cytometry (right; 
mean fluorescent intensity is indicated in the bar graph; *, P < 0.05;  
**, P < 0.01). (A and B) Data are representative of five independent experi-
ments. Values represent the mean ± SD.JEM Vol. 208, No. 10 
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Socs1+/+ Treg cells, Socs1/ Treg cells, or Ifn/Socs1/ Treg cells 
did not promote Th1 or Th17 cell differentiation, suggesting 
that cytokines from Treg cells modify the APCs for accelerated 
Th1 or Th17 cell differentiation form naive T cells (Fig. 7 C, 
top). Supernatants from Socs1/ Treg cells instructed naive 
T cells to differentiate into IL­17–producing effector cells 
when cultured with LPS­untreated APCs (Fig. 7 C, middle; 
and Fig. S6, right). This finding is consistent with our obser­
vations that Socs1/ Treg cells produced IL­17 (Fig. 4 A) and 
induced more Th17 in vivo (Fig. 6 C). This instruction of 
naive T cells was augmented by Ifn/Socs1/ Treg cells, which 
produced the largest amount of IL­17 (Fig. 7 A), consistent 
with the results shown in Fig. 6 C. When APCs were activated 
by LPS (Fig. 7 C, bottom; and Fig. S6, left), naive T cells, after 
the addition of supernatant of Socs1/ Treg cells, were in­
structed to differentiate into IFN­–producing effector cells, 
which is again consistent with higher IFN­ production from 
Socs1/ Treg cells (Fig. 4 A), and induced more Th1 in vivo 
(Fig. 6 C). Ifn/Socs1/ Treg cells did not induce Th1 in 
LPS­treated APCs, suggesting that IFN­ production from 
Treg cells plays an important role in the Th1 instruction of 
naive T cells. Both IFN­ and IL­17 antibodies abolished 
Th1  and Th17  instruction,  respectively,  confirming  that 
IFN­ and IL­17 from SOCS1­deficeint Treg cells play essen­
tial roles in Th1 and Th17 induction from naive 
T cells (Fig. S6).
To confirm the role of APCs, we examined 
the effect of anticytokine antibodies on the in 
vitro instruction experiments (Fig. S6). Th1 
instruction was eliminated by IL­12 antibodies, 
suggesting that IL­12 from APCs promoted 
Th1 cell differentiation. Consistent with this 
T cells and Ifn/Socs1/ Treg cells (Fig. 6 C, e). These data 
suggest that the cytokine profile of Treg cells instructs the di­
rection of differentiation of Th1 or Th17 from naive T cells in 
lymphopenic conditions.
Instruction of Th1 and Th17 cell differentiation  
by cytokines from Treg cells through APCs in vitro
To confirm these instructions by Treg cells, we first measured 
IL­17 from IFN­–deficient Treg cells in in vitro culture ex­
periments. As expected, Ifn/ Treg cells produced higher 
amounts of IL­17 than did WT Treg cells, and IL­17 produc­
tion was further enhanced by SOCS1 deficiency (Fig. 7 A). 
These data suggest that IFN­ usually suppressed IL­17 pro­
duction from Treg cells, which skewed Th1 cell differentiation 
from naive T cells. Coincidently, hyper­STAT1 activation was 
not observed in Ifn/Socs1/ Treg cells, although STAT3 
activation was still high (Fig. 7 B, top and bottom). Thus, 
hyper STAT3 activation could account for high levels of 
IL­17 production from Ifn/Socs1/ Treg cells.
The effect of culture supernatants of Treg cells on Th1/
Th17 cell differentiation was then examined (Fig. 7 C). Cul­
ture supernatants of Treg cells were added to the co­culture of 
naive T cells only or in the presence or absence of APCs 
(Fig. 7 C). In the absence of APCs, culture supernatants from 
Figure 5.  IFN- suppresses CNS2 methylation and 
Foxp3 loss in SOCS1-deficient Treg cells. (A) Expression 
profiles of CD62L and CD44 on CD3+CD4+CD25bright cells 
of the LN cells from Ifn/Socs1+/+ and Ifn/Socs1/  
mice. (B–D) 2 × 105 Treg cells from Ifn/Socs1+/+ mice 
or Ifn/Socs1/ mice were transferred into Rag2/ 
mice. 6 wk after transfer, recipient mice were analyzed. 
(B) Body weight changes. (C) Flow cytometric analysis of 
Foxp3 expression on CD3+CD4+ T cells from the LN in 
Rag2/ mice (percentage of Foxp3+ indicated in bar 
graph). (D) CD25 and intracellular CTLA4 expression on 
CD3+CD4+Foxp3+ cells and Foxp3 cells from the LN  
in Rag2/ mice (right) compared with those on 
CD3+CD4+CD25bright cells before transfer (left; mean  
fluorescent intensity [MFI] indicated in bar graph). Data 
are representative of three independent experiments  
(*, P < 0.05; **, P < 0.01). Values represent the mean ± SD.  
(E) Bisulfite sequencing of genomic DNA from Treg cells 
from the LN of Ifn/Socs1+/+ and Ifn/Socs1/ 
male mice. 10 CpG methylation sites in the CNS2 region 
of the Foxp3 gene were analyzed before culture (left) and 
after 3-d in vitro culture. Percentages of clones display-
ing each methylation status of CpG methylation sites are 
indicated in sector graphs. 10–15 clones were sequenced 
from each subset.2062 SOCS1 is necessary for Treg cell integrity | Takahashi et al.
well as Ifn/Socs1+/+ Treg cells suppressed colitis induced by 
IL­17–deficient naive T cell transfer (Fig. 7 D). These data 
further support our hypothesis that Ifn/ Treg cells instruct 
Th17 cell differentiation of naive T cells, thereby suppressing 
colitis less efficiently, and these processes are accelerated when 
SOCS1 is deficient in Ifn/ Treg cells.
DISCUSSION
In this study, we demonstrated that SOCS1 is necessary for 
Treg stability and suppressor functions: SOCS1 protects Treg 
cells from harmful effects of inflammatory cytokines, which 
promote the loss of Foxp3 expression and the conversion into 
Th1/Th17­like effector cells. Recent studies have shown that 
Treg cells rapidly lose Foxp3 expression upon the transfer into 
a lymphopenic host (Komatsu et al., 2009) or in inflamma­
tory conditions (Zhou et al., 2009). Such exFoxp3 cells (Zhou 
et al., 2009) or lapsed Treg cells (Murai et al., 2010) develop an 
effector­memory phenotype, produce patho­
genic cytokines, and can trigger the devel­
opment of autoimmunity. Multiple studies 
have suggested that Treg cells isolated from 
inflammatory sites express reduced amounts 
of Foxp3, possibly increasing susceptibility to 
autoimmunity (Wan and Flavell, 2007; Tang 
et al., 2008).
Foxp3 expression is regulated by various 
factors, such as Smad2/3 (Takimoto et al., 
2010), Runx1 (Kitoh et al., 2009; Rudra et al., 
2009), STAT5 (Yao et al., 2007), c­Rel (Hori, 
2010), and DNA methylation of the CNS2 
region in the Foxp3 enhancer (Zheng et al., 
2010). DNA methylation of CNS2 is partic­
ularly important because CNS2 is required 
for Foxp3 expression in the progeny of di­
viding Treg cells (Zheng et al., 2010). Surpris­
ingly, we found that the CNS2 region of 
freshly  isolated  SOCS1­deficient Treg  cells 
was fully demethylated, indicating that they 
are committed Foxp3+ Treg cells. In Rag2/ 
mice as well as in in vitro culture, part of the 
notion, Socs1/ Treg cells could not suppress colitis induced 
by Ifnr1/ naive T cells transferred into Rag2/ mice 
(Fig. S7). This experiment suggested that IFN­ from Socs1/ 
Treg cells still induced colitogenic T cells from Ifnr1/ naive 
T cells. In contrast, anti–IL­6 antibody completely inhibited 
and anti–TGF­ antibody partially inhibited Th17 instruc­
tion. Anti–IL­23 antibody did not affect Th17 cell differentia­
tion. These results suggest that IL­17 from cultured Treg cells 
stimulated IL­6 and TGF­ production from APCs, which 
promoted Th17 cell differentiation from naive T cells.
To confirm this possibility, we used IL­17–deficient naive 
T cells for the transfer. As shown in Fig. 7 D, Rag2/ mice 
transferred with IL­17–deficient naive T cells developed coli­
tis, which was less severe than in WT naive T cell transfer. 
However, Socs1/ Treg cells caused extremely severe colitis 
(Fig. 7 D), which was triggered by the large levels of IFN­ 
(not depicted). As we expected, Ifn/Socs1/ Treg cells as 
Figure 6.  Ifn/Socs1/ Treg cells fail to  
suppress colitis in vivo. (A and B) 2 × 105 Ly5.2 
Ifn/Socs1+/+ or Ly5.2 Ifn/Socs1/ Treg cells 
were cotransferred with 4 × 105 Ly5.1 naive T cells 
into Rag2/ mice. 4 wk after transfer, recipient 
Rag2/ mice were analyzed. (A) Body weight 
changes. (B) Flow cytometric analysis of Foxp3  
expression on Ly5.2+CD3+CD4+ T cells from the LN in 
Rag2/ mice (percentage of Foxp3+ indicated in  
bar graph). (C) Flow cytometric analysis of IFN-  
and IL-17A on Ly5.1+CD3+CD4+cells (top) and 
Ly5.2+CD3+CD4+ T cells (middle) from the LN  
in recipient mice (percent positivity, bottom).  
(A–C) Data are representative of three independent 
experiments (*, P < 0.05; **, P < 0.01). Values repre-
sent the mean ± SD.JEM Vol. 208, No. 10 
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committed Foxp3+ cells expanded and converted into Foxp3 
cells (i.e., exFoxp3 cells). The CNS2 region in SOCS1­deficient 
exFoxp3 cells was more methylated than that in WT Treg cells. 
Also, because the CNS2 methylation status of Treg cells was 
altered after 3­d in vitro culture and there was a partially methyl­
ated CNS2 region, it is unlikely that all of the exFoxp3 cells 
were caused by the expansion of contaminated Foxp3 effector 
T cells. Accordingly, we concluded that SOCS1 contributes 
to Treg cell integrity by maintaining stable Foxp3 expression.
Our  present  study  indicated  that  the  excessive  IFN­–
STAT1 signals resulted in faster loss of Foxp3 expression in Treg 
cells in lymphopenic conditions as well as in an in vitro culture 
system. One possibility is that the IFN­–STAT1 pathway in­
creases reprogramming from SOCS1­deficient Treg cells to ef­
fector cells. IFN­ may promote the expansion or development 
of memory type CD62Llow cells because we observed that the 
CD62Llow fraction was at normal levels in IFN­/SOCS1   
double­deficient Treg cells. STAT1 may antagonize STAT5, yet 
this is unlikely because we could not observe the reduction of 
STAT5  phosphorylation  in  our  SOCS1­deficient Treg  cells. 
STAT1 has also been shown to inhibit the TGF­–Smad path­
way (Tanaka et al., 2008). The phenotypes of Smad2/3­deficient 
Treg cells were similar to those observed in SOCS1­deficient   
Treg cells (Takimoto et al., 2010). Thus, the suppression of Smad 
signaling by STAT1 could be one of the mechanisms behind the 
reprogramming of Treg cells. The relationship between these fac­
tors and the reprogramming of Treg cells remain to be clarified.
Recently, Rubtsov et al. (2010) reported that highly puri­
fied Treg cells were very stable under physiological and inflamma­
tory conditions. Lu et al. (2010) reported that Foxp3 expression 
of SOCS1­deficient Treg cells from Foxp3Cre­Socs1f/f mice 
was maintained in the presence of naive and effector T cells, 
although the suppression activity of Socs1/ Treg cells was 
defective and IFN­ was produced from Socs1/ Treg cells 
with STAT1 hyperactivation.  Thus, Foxp3 expression in Socs1/ 
Treg cells from Foxp3Cre­Socs1f/f mice was more stable than 
that in Socs1/ Treg cells from LckCre­Socs1f/f mice. Because 
SOCS1 of LckCre­Socs1f/f mice is deleted in the Treg cell pro­
genitors, whereas SOCS1 of Foxp3Cre­Socs1f/f mice is deleted 
after Treg cell maturation, this discrepancy may be explained 
by differences in the developmental conditions of Treg cells. It 
is also possible that in LckCre­Socs1f/f mice, cytokines from 
Socs1/ effector T cells could contribute to more drastic 
phenotypic changes in Socs1/ Treg cells.
A recent study has demonstrated that during lethal Toxo-
plasma gondii infection, the exposure of WT Treg cells to high 
amounts of Th1 inflammatory mediators superimposes a Th1 
effector program on Treg cells of not only the Foxp3­losing 
portion but also the Foxp3­maintaining portion (Oldenhove 
et al., 2009). Thus, the conversion of Treg cells to Th1 is one 
of the mechanisms for uncontrolled Th1 response in STAT1­
hyperactivated Treg cells, and this process is usually protected 
by SOCS1. Recently, Lu et al. (2010) reported on the defective 
suppression activity of SOCS1­deficient Treg cells and IFN­ 
production from these Treg cells by STAT1 hyperactivation.   
In addition, our data suggest the intriguing possibility that 
Figure 7.  exFoxp3 cells instruct differentiation of naive T cells 
to Th1 and Th17 in vitro. (A) 105 Socs1+/+, Ifn/Socs1+/+, or  
Ifn/Socs1/ Treg cells/well were stimulated with anti-CD3/anti-CD28 
beads, 10 ng/ml IL-2, and the indicated cytokines, and IL-17A was 
measured by ELISA. Data are representative of five independent ex-
periments (***, P < 0.001). (B) Phosphorylation status of STAT1 and 
STAT3 in Treg cells with the indicated genotypes by flow cytometry 
(mean fluorescent intensity shown in bar graph). Data are representa-
tive of five independent experiments (**, P < 0.01). (C) 3 × 105 WT  
naive T cells/well were cultured for 5 d alone (top) or with untreated 
APCs (middle) or LPS-stimulated APCs (bottom ; 7 × 105 T cell–de-
pleted spleen cells/well) plus supernatants from Socs1+/+, Socs1/, or 
Ifn/Socs1/ Treg cells (2 × 105/well) cultured for 2 d in the pres-
ence of anti-CD3/anti-CD28 beads and 10 ng/ml IL-2. Flow cytometric 
analysis of IFN- and IL-17A on these cells is shown. Data are repre-
sentative of three independent experiments. (D) 2 × 105 Socs1+/+, 
Socs1/, Ifn/Socs1+/+, or Ifn/Socs1/ Treg cells were cotrans-
ferred with 4 × 105 Il17/ naive T cells into Rag2/ mice, and body 
weight is shown. Data are representative of three independent  
experiments (*, P < 0.05; **, P < 0.01). (A, B, and D) Values represent 
the mean ± SD.2064 SOCS1 is necessary for Treg cell integrity | Takahashi et al.
effector Th1  and Th17  cell  differentiation,  respectively,  by 
modulating APCs. It has been reported that Treg cells interact 
with DCs before naive T cells and down­regulate the expression 
of CD80/86 caused by high levels of CTLA4 on Treg cells 
(Onishi et al., 2008). Because SOCS1­deficient Treg cells lose 
CTLA4 expression, they may not be able to suppress the ex­
pression levels of co­stimulator ligands. It has been reported 
that DCs treated with IFN­ preferentially induce Th1 (Hanada 
et al., 2003), whereas IL­17–treated DCs preferentially induce 
Th17 cell differentiation because of the higher production of 
IL­1, IL­6, and IL­23 from IL­17–treated DCs (Sutton et al., 
2009). IL­17 may not directly induce Th17 cell differentiation 
in the absence of APCs because IL­17 has been reported to 
actually reduce Th17 cell differentiation (Smith et al., 2008). 
These previous studies support our results, and IFN­ and 
IL­17 from Treg cells are thought to instruct effector T cell 
differentiation into Th1 or Th17 by modulating APCs.
In conclusion, we propose the idea that SOCS1 is an 
important guardian of Treg cells. Our findings also raise the inter­
esting possibility that up­regulation of SOCS1 in Treg cells at 
appropriate levels reinforces  Treg cell functions because SOCS1 
may protect Treg cells from harmful effects of inflammatory 
cytokines that accelerate the conversion of Treg cells into ef­
fectors. These findings may improve Treg cell therapy for auto­
immune diseases and organ transplantations.
MATERIALS AND METHODS
Mice. LckCre­Socs1f/f (T cell–specific Socs1­cKO; Tanaka et al., 2008) and 
Socs1f/f (littermate control; WT) mice (sex and age matched) were used. cKO 
mice and Socs1f/f littermates crossed with knockin mice with Foxp3­IRES­GFP 
(WT­Foxp3GFP mice and cKO­Foxp3GFP mice) were provided by B. Malissen 
(Université de la Méditerranée, Marseille, France; Wang et al., 2008). Ifn/, 
Ifn/Socs1/,  Il17/,  and  Ifnr1/  mice  with  the  C57BL/6J  back­
ground were described previously (Nakae et al., 2002; Hanada et al., 2003; 
Suzue et al., 2003). Mice were kept in conventional conditions in Keio Univer­
sity. All experiments using these mice were approved by and performed accord­
ing to the guidelines of the Animal Ethics Committee of Keio University.
Histopathologic  examination. Tissue samples were obtained from the 
proximal and distal colon, skin, liver, and kidneys and then fixed in 10% neu­
tral buffered formalin, embedded in paraffin, and stained with hematoxylin 
and eosin (H&E). Assessments of the severity of colitis were performed using 
the histopathologic score as described previously (Inagaki­Ohara et al., 2004).
In vivo suppression assay and transfer colitis model in Rag2/ mice. 
Flow  cytometry–purified  4  ×  105  CD4+CD25CD62L+CD44  naive   
T cells from WT mice were injected intravenously into Rag2/ mice in 
combination with 2 × 105 CD3+CD4+CD25+Foxp3GFP cells from WT­
Foxp3GFP or cKO­Foxp3GFP mice (8 wk old and sex matched) or 2 × 105 
CD3+CD4+CD25bright Treg  cells  from  Ifn/Socs1+/+  or  Ifn/Socs1/ 
mice (8 wk old and sex matched). Mice were observed daily and weighed 
weekly. 4 wk after cell transfer, the mice were sacrificed for experiments, and 
colon sections were stained with H&E. Tissues were graded semiquantita­
tively. Histological grades were assigned in a blinded manner.
Transfer of Treg cells into Rag2/ mice. Flow cytometry–purified 2 × 105 
CD3+CD4+CD25+Foxp3GFP cells from WT­Foxp3GFP or cKO­Foxp3GFP mice 
(8 wk old and sex matched) or 2 × 105 CD3+CD4+CD25bright Treg cells from 
Ifn/Socs1+/+ or Ifn/Socs1/ mice (8 wk old and sex matched) were in­
jected intravenously into Rag2/ mice. Mice were observed daily and weighed 
weekly. 6 wk after cell transfer, the mice were sacrificed for experiments.
hyperactivation of STAT3 in Treg cells facilitates the conver­
sion to Th17­like cells, which leads to an uncontrolled response 
in effector Th17 cells. STAT5, in contrast, enhances Foxp3 
expression and the number of Treg cells (Lu et al., 2009).
Like STAT1, STAT3 has been reported to inhibit Foxp3 
expression  during  iTreg/Th17  cell  differentiation  together 
with TGF­ (Takimoto et al., 2010). However, the role of 
STAT3 in Foxp3 stability in Treg cells seems to be more com­
plicated. STAT3­deficient Treg cells have been shown to expand 
less efficiently than WT Treg cells in lymphopenic conditions 
(Durant et al., 2010) and lose their suppression activity, espe­
cially for Th17 (Chaudhry et al., 2009; Durant et al., 2010). 
Foxp3 was stable in Ifn/Socs1/ Treg cells with hyperacti­
vated STAT3. Thus, it is unlikely that the hyperactivation of 
STAT3  is  linked  to  Foxp3  instability.  Previously,  we  have 
shown that STAT3 activation is reduced in SOCS1­deficient 
naive T cells in response to IL­6 and TGF­ caused by SOCS3 
induction (Tanaka et al., 2008). The mechanism of hyperacti­
vation of STAT3 in SOCS1­deficient Treg cells remains to be 
investigated. Although Foxp3 expression of Ifn/Socs1/ 
Treg cells is stabilized, these Ifn/Socs1/ Treg cells were still 
defective in terms of the suppression of IL­17 production 
from both Treg cells and effector T cells in Rag2/ mice. This 
indicates that the stable expression of Foxp3 is not a sufficient 
condition for the suppression of effector Th17 cells. This may 
be linked to a high conversion potential of Treg cells to Th17 
cells. In a recent study using IL­17–RFP reporter mice with 
a Foxp3­GFP reporter, Yang et al. (2008) demonstrated the 
presence of a RFP+GFP+ transient phase upon T cell activation 
in vitro and in vivo. Thus, it is highly possible that both Th17 
and Treg cell programs could occur simultaneously in one cell, 
which underlies the conversion of Foxp3­positive Treg cells to 
IL­17–producing cells. We observed that STAT3 was hyper­
activated in Socs1/ Treg cells as well as in Ifn/Socs1/ 
Treg cells. Although we do not have direct proof demonstrat­
ing that STAT3 hyperactivation is responsible for the conver­
sion  of Treg  cells  to Th17,  it  is  likely  true  because  IL­17 
production from nTreg cells was enhanced by IL­6 and IL­1 
and because STAT3, in addition to TGF­ signals, has been 
shown to be an essential factor for the generation of Th17.
SOCS1­deficient Treg cells, which convert to Th1­ and 
Th17­like cells, seem to instruct naive T cells to differentiate 
into the same cytokine­producing effector T cells. This can 
also explain why STAT1 or STAT3 hyperactivated Treg cells 
cannot control Th1 or Th17 effectors, respectively. Intrigu­
ingly,  previous  studies  have  indicated  that  STAT1–T­bet 
(Koch et al., 2009) and STAT3 (Chaudhry et al., 2009; 
Durant et al., 2010) in Treg cells are required for Th1 and Th17 
suppression, respectively. Our current study, as well as a previ­
ous study (Lu et al., 2010), clearly indicates that both the lack 
of STAT1/3 and unrestrained STAT1/3 activation in Treg cells 
leads to a severe failure of immunological tolerance.
Anti–IFN­, –IL­17, –IL­12, and –IL­6 antibodies nearly 
completely inhibited Th1 and Th17 cell differentiation (Fig. S6). 
Thus, we clarified that IFN­ from Th1­converted Treg cells 
and IL­17 from Th17­converted Treg cells preferentially induced JEM Vol. 208, No. 10 
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cKO­Foxp3GFP mice before transfer or 4 wk after transfer into Rag2/ mice 
were also examined. H2O was added to 500 ng of the digested DNA to a 
volume of 19 µl, and 1.2 µl of 6N NaOH was added; the mixture was then 
incubated at 37°C for 15 min. Next, 120 µl of 3.6N Na bisulfite, 0.57 mM 
hydroquinone, and 0.3N NaOH were added. Samples were then treated with 
15 cycles of 95°C for 30 s to 50°C for 15 min. The reaction was then desalted 
using the Wizard DNA cleanup system (Promega) and eluted with 50 µl TE 
(Tris­EDTA). 3 µl of 5N NaOH was added, and the samples were incubated 
for 5 min at room temperature. The products were then ethanol precipitated 
and dissolved with 50 µl of TE buffer. The CNS2 region was PCR amplified 
with the primer set (forward, 5­TTTTGGGTTTTTTTGGTATTTAAGA­3; 
reverse,  5­TTAACCAAATTTTTCTACCATTAAC­3)  and T/A  cloned 
into a pGEM­T­Easy vector (Promega). 10 inserted plasmids from each con­
dition were purified and sequenced. 2 × 105 Treg cells before transfer and 4 wk 
after transfer into Rag2/ mice were also analyzed.
Statistical analysis. For statistical analysis, we used the Student’s t test.
Online supplemental material. Fig. S1 shows that the suppressive activity 
of SOCS1­deficient Treg cells is attenuated in Rag2/ mice. Fig. S2 shows 
colitis caused by SOCS1­deficient Treg cells in Rag2/ mice. Fig. S3 shows 
that the loss of Foxp3 expression in Treg cells is not caused by outgrowth of 
activated memory T cell contamination of injected donor cells in Rag2/ 
mice. Fig. S4 shows expression levels of IL­10 of Treg cells before and after 
transfer in Rag2/ mice. Fig. S5 shows that the suppressive activity of 
Ifn/Socs1/ Treg cells is attenuated in Rag2/ mice. Fig. S6 shows that 
anti–IFN­, –IL­17, –IL­12, and –IL­6 antibodies nearly completely inhibit 
Th1 and Th17 cell differentiation through APCs. Fig. S7 shows that Socs1/ 
Treg cells cannot suppress colitis induced by the transfer of Ifnr1/ naive   
T  cells  into  Rag2/  mice.  Online  supplemental  material  is  available  at 
http://www.jem.org/cgi/content/full/jem.20110428/DC1.
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